SCHEMBL6537997

SCHEMBL6537997

C=CCc1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1Sc1ncc[nH]1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYK2 P29597 4/20 0.42
JAK2 O60674 3/20 0.42
JAK1 P23458 3/20 0.42
ALDH1A1 P00352 2/20 0.36
HPGD P15428 1/20 0.36
HDAC1 Q13547 2/20 0.35
SLC16A3 O15427 1/20 0.34
CDK14 O94921 3/20 0.34
CCNY Q8ND76 3/20 0.34
PTGES O14684 1/20 0.33
KDR P35968 1/20 0.32
MCL1 Q07820 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPK8 P45983 2/20 0.32
MAPK10 P53779 2/20 0.32
HDAC3 O15379 1/20 0.32
NCOR1 O75376 1/20 0.32
CDK1 P06493 1/20 0.32
CCNA2 P20248 1/20 0.32
CDK2 P24941 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538030 0.84 JAK2 (0.46) TYK2JAK2JAK1HDAC1CDK14
SCHEMBL6538102 0.84 TYK2 (0.46) TYK2JAK2JAK1PTGESKDR
SCHEMBL6537693 0.80 ALDH1A1 (0.43) TYK2JAK2JAK1ALDH1A1HPGD
SCHEMBL6537625 0.78 TYK2 (0.52) TYK2JAK2JAK1HDAC1KDR
SCHEMBL6537372 0.77 TYK2 (0.43) TYK2JAK2JAK1ALDH1A1HPGD
SCHEMBL6538269 0.76 TYK2 (0.42) TYK2JAK2JAK1ALDH1A1HDAC1
SCHEMBL6538044 0.74 TYK2 (0.43) TYK2JAK2JAK1CDK14CCNY
SCHEMBL6537640 0.74 TYK2 (0.43) TYK2JAK2JAK1PTGESCYP3A4
SCHEMBL8587312 0.71 TYK2 (0.44) TYK2JAK2JAK1HDAC1SLC16A3
SCHEMBL6538034 0.71 TYK2 (0.45) TYK2JAK2JAK1HDAC1SLC16A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed